thymosin beta-4 fragment peptide

TB-500 clinical trials

Name: TB-500 clinical trials
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Answer

TB-500 has 1 registered trial: 1 running, 0 completed, 0 stopped early. 0 posted results.

Trial registerClinicalTrials.gov, read 2026-10-03

Trial	Title	Status	Phase	Registered	Results
NCT07487363 Trial register	TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD	currently recruiting participants	1/2	2026-03-23	-

Source: ClinicalTrials.gov, read 2026-10-03. Not medical advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.